Cliff Wilson was appointed market president and CEO of Albuquerque, N.M.-based Lovelace Health System, effective Aug. 11.
Mr. Wilson will replace Troy Greer, who resigned in June after two years in the role. Mr. Greer’s departure marked the five-hospital system’s fourth CEO change in three years. Michael Kueker, CEO of Lovelace Medical Group, was named interim CEO.
Mr. Wilson joins Lovelace from Lifepoint Health’s central Kentucky region, where he served as market president and CEO, according to a July 7 health system news release.
Throughout his career, he held various leadership positions at Brentwood, Tenn.-based Lifepoint, including hospital CEO, COO and senior director of physician services.
“We are thrilled to welcome Cliff to Lovelace and the Albuquerque community,” Mr. Kueker, said in the release. “His commitment to compassionate, high-quality care and his collaborative leadership style make him an ideal fit for our team. I’m confident he will continue to build on our momentum, advancing our growth, strengthening quality and expanding access to care across the region.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
